These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37385918)

  • 1. Speaking and learning across disciplines in the harm reduction debate.
    Pollack HA
    Int J Drug Policy; 2023 Nov; 121():104108. PubMed ID: 37385918
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains.
    Ostrach B; Buer LM; Armbruster S; Brown H; Yochym G; Zaller N
    J Rural Health; 2021 Jan; 37(1):252-255. PubMed ID: 32652621
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of an Unsanctioned Safe Consumption Site in the United States.
    Kral AH; Lambdin BH; Wenger LD; Davidson PJ
    N Engl J Med; 2020 Aug; 383(6):589-590. PubMed ID: 32640126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 5. Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders.
    Roberts HH; Stone M; Isac AJ
    Nurs Clin North Am; 2023 Jun; 58(2):243-256. PubMed ID: 37105658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New hope for unsanctioned safe injection site.
    Glauser W
    CMAJ; 2018 Jan; 190(3):E90-E91. PubMed ID: 29358208
    [No Abstract]   [Full Text] [Related]  

  • 7. Harm reduction and needle exchange programmes.
    Bluthenthal RN; Kral AH; Lorvick J; Erringer EA; Edlin BR
    Lancet; 1998 Jun; 351(9118):1819-20. PubMed ID: 9635989
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
    Vearrier L
    Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.
    Cloud DH; Castillo T; Brinkley-Rubinstein L; Dubey M; Childs R
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):276-282. PubMed ID: 29740734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 12. ODYSSEAS: supervised use of drugs versus bureaucracy in Greece.
    Malliori M; Galinaki S; Papakonstantinou AK
    Lancet Psychiatry; 2015 Feb; 2(2):e3. PubMed ID: 26359756
    [No Abstract]   [Full Text] [Related]  

  • 13. Harm Reduction: Front Line Public Health.
    Stancliff S; Phillips BW; Maghsoudi N; Joseph H
    J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in needle and syringe presentations point to the successes of Australian harm reduction policy and practice.
    O'Keefe D; Jacka D; Maher L
    Aust N Z J Public Health; 2023 Feb; 47(1):100016. PubMed ID: 36638580
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV and drugs: a common, common-sense agenda for 2016.
    Buse K; Albers E; Phurailatpam S
    Lancet Glob Health; 2016 May; 4(5):e292-3. PubMed ID: 27080461
    [No Abstract]   [Full Text] [Related]  

  • 17. Syringe exchange in the United States: doing the simple things better?
    Maher L; Iversen J
    Addiction; 2009 Sep; 104(9):1448-50. PubMed ID: 19558566
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital admissions among people who inject opioids following syringe services program implementation.
    Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
    Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe services programs and real-world research: An overview for pharmacists.
    Carico RR; Hussain N; Sheppard J; Thomas CB; Fenerty J
    J Am Pharm Assoc (2003); 2020; 60(5):e29-e33. PubMed ID: 32278515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Safe Syringe Exchange Programs: Role of the North Carolina Division of Public Health.
    Novick LF; Staley D; Novick CG
    J Public Health Manag Pract; 2019; 25(4):390-397. PubMed ID: 31136513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.